当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析

复星医药

(600196)

  

流通市值:441.07亿  总市值:555.98亿
流通股本:21.18亿   总股本:26.70亿

复星医药(600196)财务分析

利润表
报告期2026-09-302026-06-302026-03-312025-12-31
营业总收入30,463,029,335.9520,441,970,38610,073,223,477.0341,661,612,748.15
营业总成本29,215,995,428.4419,682,627,988.39,532,295,160.540,087,325,053.49
其他经营收益
营业利润3,929,023,074.492,615,941,075.381,375,376,200.035,228,351,339.59
利润总额3,878,773,025.462,586,571,906.931,357,544,436.175,111,983,263.87
净利润3,247,116,277.122,148,928,430.321,079,627,854.144,247,929,628.38
每股收益
其他综合收益-1,264,587,213.04-913,684,904.03-616,755,016.63-675,759,872.93
综合收益总额1,982,529,064.081,235,243,526.29462,872,837.513,572,169,755.45
资产负债表
报告期2026-09-302026-06-302026-03-312025-12-31
流动资产:
流动资产合计34,543,238,143.7734,799,347,678.2933,964,684,348.7333,820,671,330.27
非流动资产:
非流动资产合计92,243,498,806.3390,628,555,416.5689,001,703,917.3786,233,297,595.78
资产总计126,786,736,950.1125,427,903,094.85122,966,388,266.1120,053,968,926.05
流动负债:
流动负债合计35,303,449,620.7738,595,926,544.5836,580,714,242.4236,424,316,078.84
非流动负债:
非流动负债合计25,409,418,404.6623,430,053,586.7422,716,324,968.3621,789,302,995.87
负债合计60,712,868,025.4362,025,980,131.3259,297,039,210.7858,213,619,074.71
所有者权益(或股东权益):
归属于母公司股东权益合计50,304,754,985.5748,731,193,493.0349,146,744,750.4648,741,507,004.7
股东权益合计66,073,868,924.6763,401,922,963.5363,669,349,055.3261,840,349,851.34
负债和股东权益合计126,786,736,950.1125,427,903,094.85122,966,388,266.1120,053,968,926.05
现金流量表
报告期2026-09-302026-06-302026-03-312025-12-31
经营活动产生的现金流量:
经营活动现金流入小计32,657,880,589.6421,969,649,537.4311,104,892,656.8943,315,418,661.34
经营活动现金流出小计29,230,778,460.819,545,697,122.759,956,294,869.0738,102,191,782.99
经营活动产生的现金流量净额3,427,102,128.842,423,952,414.681,148,597,787.825,213,226,878.35
投资活动产生的现金流量:
投资活动现金流入小计1,531,136,266.11907,292,950.29590,290,272.153,722,258,666.04
投资活动现金流出小计7,090,183,052.555,335,391,260.842,319,574,775.555,868,024,954.77
投资活动产生的现金流量净额-5,559,046,786.44-4,428,098,310.55-1,729,284,503.4-2,145,766,288.73
筹资活动产生的现金流量:
筹资活动现金流入小计27,056,040,893.2313,929,238,711.217,953,358,102.4737,334,019,380.15
筹资活动现金流出小计24,072,693,580.5811,253,234,699.246,675,162,903.9540,578,108,887.3
筹资活动产生的现金流量净额2,983,347,312.652,676,004,011.971,278,195,198.52-3,244,089,507.15
汇率变动对现金及现金等价物的影响-319,036,554.6-222,600,992.35-158,570,564.25-176,810,748.88
现金及现金等价物净增加额532,366,100.45449,257,123.75538,937,918.69-353,439,666.41
期末现金及现金等价物余额9,570,376,221.159,487,267,244.459,576,948,039.399,038,010,120.7
补充资料:
现金及现金等价物的净增加额-449,257,123.75--353,439,666.41
最新报告期:2026-11-12
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
天风证券杨松,刘一伯1.301.551.872026-11-12
中国银河程培,宋丽莹1.361.561.732026-10-28
浙商证券郭双喜1.421.721.922026-09-24
中国银河程培,宋丽莹1.361.561.732026-08-28
TOP↑